Browsing eNauka
Browsing by Author Schernthaner, Guntram
Showing results 1 to 5 of 5
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2019 | CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle | Schernthaner, Guntram; Wanner, Christoph; Jurišić-Eržen, Dubravka; Guja, Cristian; Gumprecht, Janusz; Jarek-Martynowa, Iwona R.; Karasik, Avraham; Lalić, Nebojša  ; Mankovsky, Boris N.; Prázný, Martin;
Tankova, Tsvetalina; Tsur, Anat; Wascher, Thomas C; Wittmann, István;
| Article | 21M21 |
| 2019 | Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs | Schernthaner, Guntram; Karasik, Avraham; Abraitienė, Agnė; Ametov, Alexander S.; Gaàl, Zsolt; Gumprecht, Janusz; Janež, Andrej; Kaser, Susanne; Lalić, Katarina  ; Mankovsky, Boris N.;
Moshkovich, Evgeny; Past, Marju; Prázný, Martin; Radulian, Gabriela; Smirčić-Duvnjak, Lea; Tkáč, Ivan; Trušinskis, Kārlis;
| Article | 21aM21a |
| 2019 | SGLT2 inhibitors in T2D and associated comorbidities — differentiating within the class | Schernthaner, Guntram; Drexel, Heinz; Moshkovich, Evgeny; Zilaitiene, Birute; Martinka, Emil; Czupryniak, Leszek; Várkonyi, Tamás; Janež, Andrej; Ducena, Kristine; Lalić, Katarina ;
Tankova, Tsvetalina; Prázný, Martin; Smirčić-Duvnjak, Lea; Sukhareva, Olga; Sourij, Harald;
| Article | 22M22 |
| 2018 | Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier? | Schernthaner, Guntram; ...; Lalic, Nebojsa M; ...; (broj, koautora 17) | Article | 21aM21a |
| 2020 | Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes | Schernthaner, Guntram; ...; Lalic, Nebojsa M; ...; (broj, koautora 17) | Article | 21aM21a |